Author
Listed:
- Hong Lin
(Southern University of Science and Technology, Shenzhen)
- Yuan Yan
(Southern University of Science and Technology, Shenzhen)
- Yifan Luo
(Southern University of Science and Technology, Shenzhen
The University of Hong Kong)
- Wing Yan So
(Technology, and Research)
- Xiayun Wei
(Southern University of Science and Technology, Shenzhen)
- Xiaozhe Zhang
(Southern University of Science and Technology, Shenzhen)
- Xiaoli Yang
(Southern University of Science and Technology, Shenzhen)
- Jun Zhang
(Southern University of Science and Technology, Shenzhen)
- Yang Su
(Southern University of Science and Technology, Shenzhen)
- Xiuyan Yang
(Southern University of Science and Technology, Shenzhen)
- Bobo Zhang
(Southern University of Science and Technology, Shenzhen)
- Kangjun Zhang
(the Third People’s Hospital of Shenzhen and the Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen)
- Nan Jiang
(the Third People’s Hospital of Shenzhen and the Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen)
- Billy Kwok Chong Chow
(The University of Hong Kong)
- Weiping Han
(Technology, and Research)
- Fengchao Wang
(National Institute of Biological Sciences)
- Feng Rao
(Southern University of Science and Technology, Shenzhen)
Abstract
COP1 and COP9 signalosome (CSN) are the substrate receptor and deneddylase of CRL4 E3 ligase, respectively. How they functionally interact remains unclear. Here, we uncover COP1–CSN antagonism during glucose-induced insulin secretion. Heterozygous Csn2WT/K70E mice with partially disrupted binding of IP6, a CSN cofactor, display congenital hyperinsulinism and insulin resistance. This is due to increased Cul4 neddylation, CRL4COP1 E3 assembly, and ubiquitylation of ETV5, an obesity-associated transcriptional suppressor of insulin secretion. Hyperglycemia reciprocally regulates CRL4-CSN versus CRL4COP1 assembly to promote ETV5 degradation. Excessive ETV5 degradation is a hallmark of Csn2WT/K70E, high-fat diet-treated, and ob/ob mice. The CRL neddylation inhibitor Pevonedistat/MLN4924 stabilizes ETV5 and remediates the hyperinsulinemia and obesity/diabetes phenotypes of these mice. These observations were extended to human islets and EndoC-βH1 cells. Thus, a CRL4COP1-ETV5 proteolytic checkpoint licensing GSIS is safeguarded by IP6-assisted CSN-COP1 competition. Deregulation of the IP6-CSN-CRL4COP1-ETV5 axis underlies hyperinsulinemia and can be intervened to reduce obesity and diabetic risk.
Suggested Citation
Hong Lin & Yuan Yan & Yifan Luo & Wing Yan So & Xiayun Wei & Xiaozhe Zhang & Xiaoli Yang & Jun Zhang & Yang Su & Xiuyan Yang & Bobo Zhang & Kangjun Zhang & Nan Jiang & Billy Kwok Chong Chow & Weiping , 2021.
"IP6-assisted CSN-COP1 competition regulates a CRL4-ETV5 proteolytic checkpoint to safeguard glucose-induced insulin secretion,"
Nature Communications, Nature, vol. 12(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22941-3
DOI: 10.1038/s41467-021-22941-3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22941-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.